Source: ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ronja Weber, Naemi Haas, Astghik Baghdasaryan, Tobias Bruderer, Demet Inci, Srdjan Micic, Nathan Perkins, Renate Spinas, Renato Zenobi, Alexander Moeller. Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS. ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019

Member's Comments

No comment yet.

Related content which might interest you: Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis Source: Eur Respir J 2006; 27: 929-936 Year: 2006 Diagnostic potential of organic halides as breath biomarkers in cystic fibrosis Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing Year: 2007 Detection of elevated 2-propanol in breath samples from children with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 309s Year: 2006 Comprehensive analysis of volatile organic compounds in human breath gas samples Source: Eur Respir J 2003; 22: Suppl. 45, 131s Year: 2003 Real-time exhaled breath analysis identifies altered metabolic signature in cystic fibrosis Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis Year: 2020 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Value of exhaled volatile organic compounds in monitoring airway disease Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases Year: 2013 Volatile markers of pulmonary tuberculosis in the breath Source: Annual Congress 2004 - Genetics and immunology of tuberculosis Year: 2004 Ionic composition of exhaled breath condenesate in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 8s Year: 2001 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012